secwatch.observer — SEC 8-K summary
======================================

Issuer:     NexImmune, Inc. (—)
CIK:        0001538210
Form:       8-K
Filed at:   2023-12-01T23:59:59+00:00
Accession:  0001193125-23-287306
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

NexImmune receives Nasdaq delisting notice for being a 'public shell'; plans appeal
--------------------------------------------------------------------------------

- Nasdaq notified NexImmune on Nov 30, 2023 it is a 'public shell' under Listing Rule 5101.
- Continued listing deemed not warranted; company subject to delisting unless timely appeal.
- Company intends to request a hearing, which automatically stays delisting pending outcome.
- No assurance of maintaining listing; trading in securities is highly speculative.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1538210/000119312523287306/0001193125-23-287306-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1538210/000119312523287306/d624909d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-287306

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer